Kevin Walton

Kevin Walton is a seasoned professional in corporate development and business strategy with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Director of Corporate Development at Moderna since 2023, Walton previously held the position of Vice President of Corporate Development at StrideBio, Inc. from 2022 to 2023 and Senior Director of Business Development at Curis from 2021 to 2022. Walton's roles at G1 Therapeutics, Inc. included Director of Corporate Development & Strategy, Chief of Staff, and Senior Manager of Business Development. Walton's career began with a foundation in finance and strategy at Amgen and Eli Lilly and Company, complemented by internships in corporate development and public policy. Walton's academic credentials include a Juris Doctor magna cum laude from Duke University School of Law, an MBA as a Fuqua Scholar from Duke University's Fuqua School of Business, and a Bachelor of Arts in Economics and History, magna cum laude, from Boston College.